SP-D was in turn suggested to be useful as a marker of risk of early lung cancer in smokers and ex-smokers: its low concentration in bronchoalveolar lavage fluid (BALF) was found to be associated with progression of bronchial dysplasia [35]. Here, SFTPD is linked to lung cancer.